U.S. Veterinary Regenerative Medicine Market Size & Outlook
U.S. veterinary regenerative medicine market, 2018-2030 (US$M)
Related Markets
U.S. veterinary regenerative medicine market highlights
- The U.S. veterinary regenerative medicine market generated a revenue of USD 61.8 million in 2022 and is expected to reach USD 137.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.5% from 2023 to 2030.
- In terms of segment, stem cells was the largest revenue generating product in 2022.
- Other Products is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary regenerative medicine market data book summary
| Market revenue in 2022 | USD 61.8 million |
| Market revenue in 2030 | USD 137.2 million |
| Growth rate | 10.5% (CAGR from 2022 to 2030) |
| Largest segment | Stem cells |
| Fastest growing segment | Other Products |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stem cells, Other Products |
| Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.7% of the global veterinary regenerative medicine market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. veterinary regenerative medicine market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 21.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Regenerative Medicine Market Scope
Veterinary Regenerative Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. veterinary regenerative medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.43% in 2022. Horizon Databook has segmented the U.S. veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of major industry players, such as AniCell Biotech, Zoetis Inc., Acell Inc. (Integra Lifesciences), Animal Cell Therapies, Inc., and Vetbiologics, has positively influenced the veterinary regenerative medicine market. These companies heavily invest in R&D to produce novel veterinary medicine to cater to demand.
For instance, AniCell Biotech offers CanisCell AniMatrX D, CanisCell AniOcular, and CanisCell AniOcular D for wound coverage. New cell and tissue therapies for animals are actively being researched in veterinary regenerative medicine. Animal Cells, Tissues, and cell- and tissue-based Products (ACTPs) are used in these treatments. These are animal products that contain, consist of, or are formed from cells or tissues.
Reasons to subscribe to U.S. veterinary regenerative medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. veterinary regenerative medicine market databook
-
Our clientele includes a mix of veterinary regenerative medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. veterinary regenerative medicine market size, by product, 2018-2030 (US$M)
U.S. Veterinary Regenerative Medicine Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
